期刊文献+

5-氟尿嘧啶胃漂浮滞留缓释片的制备 被引量:7

Preparation of the 5-Fu floating sustained release tablet for gastric retention
下载PDF
导出
摘要 目的 :以 5 氟尿嘧啶 (5 Fu)为模型药物 ,制备一种漂浮性能不受胃中酸度影响的漂浮缓释片剂。方法 :根据流体动力学原理 ,采用漂浮层和载药层分别制粒再一起压片的方法 ,制备 5 Fu双层漂浮型胃内滞留缓释片 ,并测定其在不同酸度介质中的漂浮动力学及药物释放规律。结果 :以优化配方所制备的双层漂浮缓释片在pH 2~ 7的介质中漂浮性能良好 ,药物的体外释放可以通过辅料成分的变化进行调节 ;1 0 0r/min转速下 ,在 0 .1mol/LHCl中 ,体外药物释放符合一级动力学规律。结论 :本研究制备的胃内漂浮滞留缓释片的漂浮性能不因胃内酸度的变化而改变 。 Objective: To develop a pH independent floating sustained release tablet for gastric retention using 5 Fluorouracil (5 Fu) as a model drug. Methods: According to the theory of the Hydro dynamically Balanced System, the granules for the floating and drug loading layer were prepared separately and pressed together to make two layer floating tablets for gastric retention. The floating kinetics indexes were measured and the data about drug release studied with media of different pH values. Results: An excellent floating ability was observed in the media of different acidity for the gastric retentive tablet prepared according to the optimum formulation. The in vitro drug release can be modified by the regulation of the formulation ingredients. At the rotating speed of 100 r/min and in 0.1 mol/L HCl, the drug release was found to conform to first class dynamics rule. Conclusion: The two layer floating tablet made in this experiment,whose floating ability is independent of the gastric acidity variation, is of the possibility to be used for the auxiliary treatment of gastric carcinoma because of its prolonged gastric retention.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2004年第4期439-442,共4页 Journal of Peking University:Health Sciences
基金 国家"2 11"工程 教育部教育振兴行动计划特殊专项 ("九八五"工程 ) 国家教委跨世纪优秀人才计划基金资助~~
关键词 5-氟尿嘧啶 胃漂浮滞留缓释片 5-FU 辅助治疗 胃疾病 HBS Fluorouracil Delayed action preparations Stomach diseases
  • 相关文献

参考文献9

  • 1Thanoo BC, Sunny MC, Jayakrishnan A. Oral sustained release drug delivery systems using polycarbonate microsphere capable of floating on the gastric fluid[J]. J Pharm Pharmacol, 1993, 45:21 -24
  • 2Patel VR, Amiji MM. Preparation and characterization of freeze dried chitosan poly (ethylene oxide) hydrogels for site- specific antibiotics delivery in stomach [J]. Pharm Res, 1996,13:588 - 593
  • 3Timmermans J, Moees AJ. How well do floating dosage-forms float[J]? Int J Pharm, 1990,62:207 -216
  • 4Wei ZP, Yu ZF, Bi DZ. Design and evaluation of a two layer floating tablet for gastric retention using cisapride as a model drug[J]. Drug Der Ind Pharm, 2001,27:469 -474
  • 5Deshpande AA, Shah NH, Rhodes CT. Development of a novel controlled release system for gastric retention[J]. Pharm Res, 1997,14:815 -819
  • 6Agyilirah GA, Green M, Du Cret R, et al. Evaluation of the gastric retention properties of a cross-linked polymer coated tablet versus those of a non disintegrating tablet[J]. Int J Pharm, 1991,75: 241- 247
  • 7Deshpand AA. Controlled release drug delivery system for prolonged gastric residence, An overview[J]. Drug Dev Ind Pharm, 1996, 22:531 -539
  • 8Ichikawa M, Watanabe S, Miyake Y. A new multiple-unit oral floating dosage systems. 1: Preparation and in vitro evaluation of floating and sustained-release characteristics [J]. J Pharm Sci, 1991,80:1062 - 1066
  • 9Viness P, Reza F. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method [J]. J Control Release, 1998,55:45 - 55

同被引文献132

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部